A new report by McKinsey & Company and the World Federation of the Sporting Goods Industry explores the state of the industry and growth themes for 2025 and beyond
HOW SPORTING GOODS BRANDS CAN TURN UNCERTAINTY INTO OPPORTUNITY BERN, Switzerland, March…
Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients
PALMA DE MALLORCA, Spain, March 5, 2025 /PRNewswire/ — Laminar Pharma, a leader…